Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial - Wilcock, G; Black, S; Haworth, J; Laughlin, M; Hendrix, S; Binger, M; Zavitz, K; Swabb, E; Hobden, A (2005)